The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2025

Filed:

Jan. 13, 2022
Applicant:

Galvanize Therapeutics, Inc., San Carlos, CA (US);

Inventors:

Timothy J. O'Brien, Santa Clara, CA (US);

Quim Castellvi, Barcelona, ES;

Luis L. Mangual Arbelo, Sunnyvale, CA (US);

Jonathan R. Waldstreicher, West Orange, NJ (US);

Seth S. Gleiman, Guilford, CT (US);

Nicholas S. Mercer, San Francisco, CA (US);

Kevin J Taylor, San Mateo, CA (US);

Robert E. Neal, Ii, Redwood City, CA (US);

William S. Krimsky, Forest Hill, MD (US);

Armaan G. Vachani, Foster City, CA (US);

Assignee:

Galvanize Therapeutics, Inc., San Carlos, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1482 (2013.01); A61B 18/1492 (2013.01); A61B 2018/00041 (2013.01); A61B 2018/00083 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00559 (2013.01); A61B 2018/00577 (2013.01); A61B 18/1477 (2013.01);
Abstract

Devices, systems and methods are provided for treating conditions of the reproductive tract. A number of conditions can afflict the lining and cell layers deeper within the anatomical structures. For example, cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is a condition involving abnormal growth of cells on the surface of the cervix that could potentially lead to cervical cancer in situ (CIS). Other conditions include human papillomavirus (HPV)-related cervical disease, various endometrial diseases, acute and chronic cervicitis, and various infections (e.g. trichomoniasis) to name a few. In some embodiments, treatments eliminate diseased, damaged, abnormal or otherwise undesired cells leaving the tissue framework intact. This allows the tissue to regenerate in a normal fashion, avoiding the formation of scar tissue. When the tissue framework is left intact, the framework structure repopulates with healthy cells, regenerating the normal tissue without altering the structural properties.


Find Patent Forward Citations

Loading…